JK, C., JL, W., ZD, Y., SP, L., ZC, L., K, C., . . . JH, Z. (2026). Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study. Liver cancer. https://doi.org/10.1159/000551629
Chicago Style (17th ed.) CitationJK, Chen, et al. "Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study." Liver Cancer 2026. https://doi.org/10.1159/000551629.
MLA (9th ed.) CitationJK, Chen, et al. "Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study." Liver Cancer, 2026, https://doi.org/10.1159/000551629.
Warning: These citations may not always be 100% accurate.